3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pancreatic Neoplasms
3
Multiple Myeloma
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Solid Tumor
2
Neoplasms
2
Melanoma
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Refractory or Relapsed Solid Tumors
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms, Plasma Cell
1
Malignant Solid Tumour
1
Lymphangioleiomyomatosis
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Gastrointestinal Neoplasms
1
Estrogen Receptor Positive Breast Cancer
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Bone Metastases
1
Adult Solid Neoplasm
1
Interventions
Sirolimus
2
temsirolimus
1
saracatinib
1
Valproic Acid
1
Immunoglobulin G
1
Imatinib Mesylate
1
Hydroxychloroquine
1
Glutamine
1
Disulfides
1
Cetuximab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lymphangioleiomyomatosis
×
Hydroxychloroquine
×
Clear all
NCT01687179
2018-10-11
SAIL
Brigham and Women's Hospital
Phase 1
Completed
14 enrolled
14 charts